Aaron P Mitchell
Overview
Explore the profile of Aaron P Mitchell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
181
Citations
6813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
de Assis L, Bain J, Liddle C, Leaves I, Hacker C, Peres da Silva R, et al.
mBio
. 2022 Oct;
13(6):e0260522.
PMID: 36218369
Candida albicans exists as a commensal of mucosal surfaces and the gastrointestinal tract without causing pathology. However, this fungus is also a common cause of mucosal and systemic infections when...
32.
Case N, Berman J, Blehert D, Cramer R, Cuomo C, Currie C, et al.
G3 (Bethesda)
. 2022 Sep;
12(11).
PMID: 36179219
The fungal kingdom represents an extraordinary diversity of organisms with profound impacts across animal, plant, and ecosystem health. Fungi simultaneously support life, by forming beneficial symbioses with plants and producing...
33.
Zarnowski R, Sanchez H, Jaromin A, Zarnowska U, Nett J, Mitchell A, et al.
Proc Natl Acad Sci U S A
. 2022 Sep;
119(38):e2211424119.
PMID: 36095193
Extracellular vesicles mediate community interactions among cells ranging from unicellular microbes to complex vertebrates. Extracellular vesicles of the fungal pathogen are vital for biofilm communities to produce matrix, which confers...
34.
Do E, Cravener M, Huang M, May G, McManus C, Mitchell A
mBio
. 2022 Aug;
13(5):e0193722.
PMID: 35993746
Candida albicans is among the most significant human fungal pathogens. However, the vast majority of C. albicans studies have focused on a single clinical isolate and its marked derivatives. We...
35.
Mitchell A, Mishra Meza A, Trivedi N, Bach P, Gonen M
Oncologist
. 2022 Aug;
27(10):857-863.
PMID: 35946837
Background: Drug manufacturers claim that the purpose of financial payments to physicians is to facilitate education about new drugs. This claim suggests 2 testable hypotheses: payments should not be associated...
36.
Mao Y, Solis N, Sharma A, Cravener M, Filler S, Mitchell A
mSphere
. 2022 Jul;
7(4):e0030522.
PMID: 35862800
Engineered conditional gene expression is used in appraisal of gene function and pathway relationships. For pathogens like the fungus Candida albicans, conditional expression systems are most useful if they are...
37.
Mitchell A, Mishra Meza A, Panageas K, Lipitz-Snyderman A, Farooki A, Morris M
Prostate Cancer Prostatic Dis
. 2022 Jul;
26(1):126-132.
PMID: 35798857
Background: Bone modifying agents (BMAs) prevent skeletal related events among patients with metastatic, castration-resistant prostate cancer (mCRPC) involving bone and prevent osteoporotic fractures among patients at high risk. BMA utilization...
38.
Phan Q, Solis N, Lin J, Swidergall M, Singh S, Liu H, et al.
PLoS Pathog
. 2022 Jul;
18(7):e1010681.
PMID: 35797411
During hematogenously disseminated candidiasis, blood borne fungi must invade the endothelial cells that line the blood vessels to infect the deep tissues. Although Candida albicans, which forms hyphae, readily invades...
39.
Mitchell A, Trivedi N, Bach P
Med Care
. 2022 Feb;
60(4):287-293.
PMID: 35149663
Background: The Prescription Drug User Fee Act (PDUFA) is due for reauthorization in 2022. Beyond creating the user fee program which now generates a majority of the Food and Drug...
40.
Solis N, Wakade R, Glazier V, Ollinger T, Wellington M, Mitchell A, et al.
mBio
. 2022 Jan;
13(1):e0344721.
PMID: 35012341
Oropharyngeal candidiasis (OPC) is a common infection that complicates a wide range of medical conditions and can cause either mild or severe disease depending on the patient. The pathobiology of...